Laminar es la primera empresa que ha conseguido llevar un producto patentado en una Universidad española hasta las últimas fases de un ensayo clínico: el LAM561

by Laminar Pharma

Este compuesto es un derivado sintético lipídico que puede administrarse oralmente, con un perfil de seguridad sobresaliente y que presenta resultados prometedores en pacientes con tumores sólidos ...

Read more

Agomab Announces $89 Million Series D Financing, with the participation of Asabys, to Support Broad Fibrosis-focused Pipeline

by Asabys Partners

Agomab Therapeutics has announced a $89 million Series D financing round, with participation from new investors Sanofi and Invus, as well as existing investors as Asabys.

Read more

ORYZON reports financial results and corporate update for quarter ended September 30, 2024

by Oryzon Genomics

Oryzon Genomics, a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, today reported financial results for the nine months...

Read more

Exclusive Insights: How the Digital Health Technology Revolution Is Changing Pharma

by Rubió

The digital health technology revolution is not just a trend; it’s reshaping patient care and pharma engagement right now.

Read more

Mineralys Therapeutics Completes Enrollment Ahead of Schedule in Launch-HTN, the Second Pivotal Trial of Lorundrostat for the Treatment of Hypertension

by Ysios Capital

Mineralys Therapeutics today announced that it has completed enrollment in the Launch-HTN trial ahead of schedule. Launch-HTN is the second of two trials under the planned pivotal program evaluating t...

Read more

How artificial intelligence is contributing to cancer research at the CNIO

by CNIO - Centro Nacional de Investigaciones Oncológicas

The research community recognizes the arrival of artificial intelligence (AI) as a revolution, a “paradigm shift” that affects all areas of research.

Read more

The voice of patients as a driving force in clinical trials

by Vall d’Hebron

Active participation by patients and families in studies helps identify more effective therapies that improve quality of life and survival.

Read more

Biointaxis hosts a webinar on how to invest in its gene therapy FRATAXAV® for Friedreich’s ataxia

by Biointaxis

Biointaxis, an academic spin-off from the Germans Trias i Pujol Research Institute (IGTP) founded in 2018, is developing the first drug designed to prevent and reverse the neurological and cardiac eff...

Read more

Next-generation SERD camizestrant significantly reduces risk of disease progression in patients with advanced ER+ HER2- breast cancer

by VHIO

The phase II SERENA-2 randomized, multi-dose clinical trial compared the efficacy of next-generation SERD camizestrant (developed by AstraZeneca) with fulvestrant.

Read more

Laminar Pharma cierra la ronda de financiación por un total de 5,9 millones de euros

by Laminar Pharma

Laminar Pharma es una empresa biotecnológica española que está desarrollando su principal compuesto LAM561, un derivado sintético del ácido oleico que puede ingerirse por vía oral. Este fármaco...

Read more

Overcoming Animal Testing with Advanced Cell Models

by Sartorius Stedim Spain

“How do we break the walls of realizing the full potential of organoids and microtissues as an alternative to animal testing?” In line with the motto of the Falling Walls Science Summit 2024 in Be...

Read more

Investigadores del IMIBIC logran un hidrogel para el tratamiento de úlceras y heridas difíciles

by Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC)

El Proyecto Macaon, desarrollado por investigadores del IMIBIC, el Hospital Reina Sofía y la Universidad de Córdoba en colaboración con la industria farmacéutica, ha alcanzado un importante hito e...

Read more
Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Telum Therapeutics Secures €18 Million...

by Telum Therapeutics

Telum Therapeutics, a biotechnology company leveraging proprietary met...

Photos Stream